The goal of treating acute Kawasaki disease (KD) is to treat inflammation and reduce cardiovascular sequelae by reducing the inflammation of the coronary arteries. We reviewed the clinical studies that focused on the efficacy of medications used for KD. Intravenous immunoglobulin (IVIG) is the ...
Kawasaki disease is an acute systemic vasculitis of unknown etiology that has become the most common form of acquired heart disease in young children in de
Kawasaki disease is the leading cause of childhood-onset acquired heart disease in developed countries, and if left untreated, leads to complications of coronary artery aneurysms (CAA) in approximately 25% of cases. While the gold standard treatment remains intravenous immunoglobulin (IVIG) and ...
(7) If the echocardiogram is positive, treatment should be given to children within 10 d of fever onset and those beyond day 10 with clinical and laboratory signs (CRP, ESR) of ongoing in?ammation. (8) Typical peeling begins under nail bed of ?ngers and then toes. disease.2,3 In ...
Treatment of the acute phase of Kawasaki disease (KD) remains controversial. Although aspirin plus intravenous gamma globulin (IVGG), the current treatment of choice, reduces coronary aneurysm formation to less than 5%, some children still develop aneurysms despite the use of high-dose IVGG. In ...
Kawasaki disease (KD) is a self-limited vasculitis affecting medium-sized vessels with a predilection for the coronary arteries. Although treatment reduces the likelihood of developing of coronary artery aneurysms, 5% of patients still develop aneurysms despite treatment, making KD the leading cause of...
Kawasaki disease_药学行业词汇 川崎病 "又称 :川崎病(MCLS,mucocutaneous lymph node syndrome) " Kawasaki disease词源英文解释 Tomisaku Kawasaki born 1925 Japanese pediatrician The first known use of Kawasaki disease was in 1975 Kawasaki disease医学词典英英释义 ...
intravenous immunoglobulin treatmentKawasaki diseaseprincipal symptomBackground Incomplete Kawasaki disease (iKD) showed a higher incidence of coronary artery abnormalities (CAAs) compared with complete KD (cKD). However, the incidence of CAAs among iKD patients may have changed recently Methods We examined...
Treatment of Kawasaki disease before day 5 of illness was associated with persistent/recrudescent fever that required retreatment. However, there was no significant increase in the prevalence of coronary aneurysm if retreatment was given. 展开 关键词: Kawasaki disease Early treatment Efficacy ...
(CAA), making it the most common cause of acquired heart disease in children. Although treatment with intravenous immunoglobulin (IVIG) and aspirin has diminished the incidence of CAA from 20% to 25% to about half, IVIG resistance occurs in up to 20% to 40% of cases and is associated ...